Showing results (161-170 of 251) with videos related to

Sort By:
Pageof 26
Lung Cancer (Amsterdam, Netherlands)|March 16, 2021
Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancerKiyotaka Yoh, Takashi Seto, Miyako Satouchi, et al.
Lung Cancer (Amsterdam, Netherlands)|February 18, 2014
A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901)Haruyasu Murakami, Nobuyuki Yamamoto, Taro Shibata, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and β III-tubulin in thymic epithelial tumorsKyoichi Kaira, Masakuni Serizawa, Yasuhiro Koh, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2014
Molecular profiling of small cell lung cancer in a Japanese cohortKazushige Wakuda, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.
Oncology Letters|August 1, 2012
Differential efficacy of docetaxel according to non-small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitorsSatoru Miura, Haruyasu Murakami, Akihiro Tamiya, et al.
American Journal of Clinical Oncology|December 6, 2012
The impact of clinical outcomes according to EGFR mutation status in patients with locally advanced lung adenocarcinoma who recieved concurrent chemoradiotherapyHiroaki Akamatsu, Kyoichi Kaira, Haruyasu Murakami, et al.
Investigational New Drugs|April 10, 2023
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatmentsShota Omori, Koji Muramatsu, Takuya Kawata, et al.
Investigational New Drugs|September 21, 2020
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinomaHiroaki Kodama, Kazushige Wakuda, Michitoshi Yabe, et al.
Japanese Journal of Clinical Oncology|October 13, 2021
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitorsKazushige Wakuda, Michitoshi Yabe, Hiroaki Kodama, et al.
Thoracic Cancer|June 20, 2025
Effect of Cancer Cachexia on the Efficacy and Treatment Delivery of Chemotherapy in Older Patients With Advanced Small Cell Lung CancerMichitoshi Yabe, Tateaki Naito, Suguru Matsuda, et al.
Pageof 26